BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Kansai Nerolac Paints Ltd. has introduced multiple discounted cash flow-accretive initiatives under the leadership of Mr. Anuj Jain, Managing Director such as-
steady expansion of innovative product portfolio across sub-segments,
relaunched brand as ‘Nerolac Paint plus with Japanese technology’ supported by higher brand and research and development spends,
investments in projects, Next-gen painting services and influencer reach to connect with customers and generate pipeline,
Kansai has also expanded dealer reach to 31,000 outlets in FY23 from 19,000 in FY19 and has also leveraged distribution model to improve coverage of smaller cities and rural markets.
We also believe differentiated product offerings in Industrial coatings and industry tailwinds like automotive recovery and commodity price correction offer growth and margin tailwinds.
Upgrade to 'Add' as risk of higher competition appears priced in after flat one-year stock performance.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

JSW Paints Gets CCI Nod To Acquire Majority Stake In Akzo Nobel India


Kansai Nerolac Q1 Review: PL Capital Retains 'Add' On Favorable Risk-Reward — Check Target Price


Kansai Nerolac Q1 Results: Profit Down 4%


Marico, Aurobindo Pharma, Kansai Nerolac, DLF, Escorts Kubota Q1 Results Today — Earnings Estimates
